Vegan and vegetarian supplements are becoming increasingly important in European private label manufacturing. Demand for plant-based products continues to grow.
In practice, developing vegan and vegetarian supplements is not only a positioning decision. It involves technical considerations related to ingredient sourcing, excipient selection, capsule materials, and manufacturing control within the EU regulatory framework.
This article explains how vegan and vegetarian supplements are developed in European manufacturing, with a focus on capsules and tablets, and what brands should consider before selecting this positioning.
Vegan and vegetarian supplement manufacturing in Europe works best when:
Plant-based positioning is achievable—but only when formulation and manufacturing constraints are addressed from the beginning.
Demand for vegan and vegetarian supplements continues to increase across European markets.
Brands choose this positioning for several reasons:
In many cases, vegan positioning is no longer a niche—it is becoming a standard expectation in categories such as daily wellness, magnesium, and multivitamin products.
Although often grouped together, vegan and vegetarian supplements are not identical.
From a manufacturing perspective, the key differences relate to:
Defining the target positioning early is essential to avoid reformulation later in the project.
Capsules and tablets are the most widely used formats for vegan and vegetarian supplements in Europe.
Both formats are generally suitable for plant-based positioning, but they require careful selection of raw materials and manufacturing processes.
For capsules, the most important factor is the capsule shell material.
HPMC capsules are compatible with most formulations and are commonly used in EU private label projects. However, they may differ slightly in:
For more detail, see our guide on Private Label Capsule Manufacturing in Europe.
Tablets can be produced as vegan products, but only if all formulation components meet plant-based requirements.
Key factors include:
In practice, tablets are often one of the most straightforward formats to adapt for vegan positioning.
For manufacturing considerations, see Private Label Tablet Manufacturing in Europe.
Achieving vegan or vegetarian positioning depends on the entire formulation—not only the dosage form.
Important considerations include:
Certain ingredients may have multiple sourcing options, making supplier verification essential.
Even when all ingredients are plant-based, manufacturing conditions must be considered.
Potential risks include:
In EU manufacturing, full segregation is not always required, but risk assessment and process control must be documented.
Clear communication with the manufacturer ensures that vegan positioning is technically supported.
In the European Union, vegan and vegetarian claims are not defined by a single harmonized regulation.
However, food supplements must comply with general food law and labeling requirements.
In the EU, food supplements are regulated under Directive 2002/46/EC and must comply with general food law, including Regulation (EC) No 178/2002.
From a practical perspective, this means:
Some brands choose third-party vegan certifications, but these are voluntary and market-driven.
Packaging does not define vegan status, but it influences positioning and product stability.
Important considerations include:
For example, bottles and blister packaging are commonly used for vegan capsules and tablets in EU manufacturing.
For more detail on stability, see our guide on supplement shelf life in Europe.
To develop vegan or vegetarian supplements efficiently, brands should define:
Providing this information early allows manufacturers to assess feasibility without delays.
In private label manufacturing, vegan supplements are typically:
At PharmaEurope, vegan feasibility is assessed during early project evaluation to ensure alignment between formulation, manufacturing, and regulatory requirements.
Vegan and vegetarian supplements in Europe require more than a label claim—they depend on formulation design, capsule selection, and manufacturing control.
Capsules and tablets are the most practical formats for plant-based positioning, but both require careful evaluation of ingredient origin and production conditions.
Brands that define these factors early are more likely to achieve stable products and consistent regulatory compliance.
If you are considering vegan or vegetarian supplements in Europe, align early on:
Early alignment reduces reformulation risk and supports efficient production.
© 2026 PharmaEurope.